| Fasudil | IC50 | 780.0 [1], 4000.0 [2] |
| Cyclohexanecarboxamide, 4-[(1R)-1-aminoethyl]-N-4-pyridinyl-, trans- | IC50 | 600.0 [1] |
| Staurosporine | IC50 | 2.2 [1] |
| Y-27632 Dihydrochloride | IC50 | 70.0 [1] |
| Crizotinib | IC50 | 10000.0 [1] |
| (4S,6Z,9S,10S)-9,10,18-Trihydroxy-16-methoxy-4-methyl-3-oxabicyclo[12.4.0]octadeca-1(14),6,15,17-tetraene-2,8-dione | IC50 | 10000.0 [1] |
| CID 59604787 | IC50 | 10000.0 [1] |
| CID 44814409 | IC50 | 10000.0 [1] |
| 7-Chloro-3-oxo-8-(1,3-thiazol-5-ylmethylamino)-11,16-dioxa-2,4,19,21-tetrazatricyclo[15.3.1.05,10]henicosa-1(20),5,7,9,17(21),18-hexaene-18-carbonitrile | Ki | 8195.0 [1] |
| 1-({4-[(3,4-Dichlorophenyl)methoxy]phenyl}methyl)azetidine-3-carboxylic acid | IC50 | 10000.0 [1] |
| N'-(3-Pyridin-4-yl-2,6-naphthyridin-1-yl)ethane-1,2-diamine | IC50 | 7.0 [1] |
| cis-3-[4-Amino-7-(3-azetidin-1-ylmethyl-cyclobutyl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]-phenol | IC50 | 2400.0 [1] |
| (13R,15S)-13-Methyl-16-oxa-8,9,12,22,24-pentazahexacyclo[15.6.2.16,9.112,15.02,7.021,25]heptacosa-1(24),2,4,6,17,19,21(25)-heptaene-23,27-dione | IC50 | 1000.0 [1] |
| N-(7-Chloro-1-oxo-1,2-dihydroisoquinolin-6-yl)-2-(dimethylamino)-2-phenylacetamide | IC50 | 2300.0 [1] |
| N-(7-Chloro-1-oxo-1,2-dihydroisoquinolin-6-yl)-2-(cyclopropylamino)-2-phenylacetamide | IC50 | 8000.0 [1] |
| N-(7-Chloro-1-oxo-1,2-dihydroisoquinolin-6-yl)-2-(methylamino)-2-phenylacetamide | IC50 | 110.0 [1] |
| 2-Methyl-N~1~-[3-(Pyridin-4-Yl)-2,6-Naphthyridin-1-Yl]propane-1,2-Diamine | IC50 | 17.0 [1] |
| (3S,4R)-N-(7-Chloro-1-oxo-1,2-dihydroisoquinolin-6-yl)-4-(4-chlorophenyl)pyrrolidine-3-carboxamide | IC50 | 14.0 [1] |
| 2-Amino-N-(7-chloro-1-oxo-1,2-dihydroisoquinolin-6-yl)-2-phenylacetamide | IC50 | 510.0 [1] |
| 7,8-Dichloro-9-methyl-1-oxospiro[2,4-dihydropyrido[3,4-b]indole-3,4'-piperidine]-4-carbonitrile | IC50 | 300.0 [1] |
| 9-Cyclopentyl-N2-[4-(4-methylpiperazin-1-yl)phenyl]-N8-phenyl-purine-2,8-diamine | IC50 | 10000.0 [1] |
| 6-(2,4-Difluorophenyl)sulfonyl-2-(1H-indol-5-ylamino)-8-methylpyrido[2,3-d]pyrimidin-7-one | IC50 | 10000.0 [1] |
| 2-[3-(Methanesulfonamido)phenyl]-N-[4-(1H-pyrrolo[2,3-b]pyridin-3-yl)-1,3-thiazol-2-yl]acetamide | Ki | 77.0 [1] |
| 2-Methyl-1-N-(2-pyridin-4-ylpyrido[3,4-d]pyrimidin-4-yl)propane-1,2-diamine | IC50 | 58.0 [1] |
| 2-(1H-Indazol-5-yl)-4-piperazin-1-ylquinazoline | IC50 | 995.0 [1] |
| 3-(1H-Indazol-5-yl)-1-piperazin-1-ylisoquinoline | IC50 | 920.0 [1] |
| N'-[2-(1H-Indazol-5-yl)quinazolin-4-yl]ethane-1,2-diamine | IC50 | 951.0 [1] |
| N'-[2-(1H-Indazol-5-yl)quinazolin-4-yl]propane-1,3-diamine | IC50 | 1000.0 [1] |
| 2-(1H-Indazol-5-yl)-4-(4-methylpiperazin-1-yl)quinazoline | IC50 | 1000.0 [1] |
| N-(7-Chloro-1-oxo-1,2-dihydroisoquinolin-6-yl)-2-phenylacetamide | IC50 | 1400.0 [1] |
| 4-(2-Chloro-4-fluorophenyl)-8-(2,6-dichlorophenyl)-7-oxido-1,7-naphthyridin-7-ium | IC50 | 10000.0 [1] |
| N-[3-(4-Dimethylaminomethyl-phenylcarbamoyl)-benzyl]-3,4-dimethoxy-benzamide | IC50 | 5000.0 [1] |
| 3-Chloro-N-[3-(4-dimethylaminomethyl-phenylcarbamoyl)-benzyl]-4-methoxy-benzamide | IC50 | 5000.0 [1] |
| 3,4-Dimethoxy-N-[3-(3-piperidin-3-yl-propionylamino)-benzyl]-benzamide | IC50 | 5000.0 [1] |
| 3-[3-(4-Cyano-phenyl)-ureidomethyl]-N-(1,2,3,4-tetrahydro-isoquinolin-7-yl)-benzamide | IC50 | 1600.0 [1] |
| 3-[3-(4-Cyano-phenyl)-ureidomethyl]-N-(2-piperidin-3-yl-ethyl)-benzamide | IC50 | 1700.0 [1] |
| 3-[3-(3-Cyano-phenyl)-ureidomethyl]-N-(2-piperidin-3-yl-ethyl)-benzamide | IC50 | 5000.0 [1] |
| 3-[3-(4-Cyano-phenyl)-ureidomethyl]-N-(4-dimethylaminomethylphenyl)-benzamide | IC50 | 5000.0 [1] |
| 3,4-Dimethoxy-N-[3-(2-piperidin-3-yl-ethylcarbamoyl)-benzyl]-benzamide | IC50 | 4400.0 [1] |
| 3,4-Dimethoxy-N-[3-(1,2,3,4-tetrahydro-isoquinolin-7-ylcarbamoyl)-benzyl]-benzamide | IC50 | 5000.0 [1] |
| 3,4-Dimethoxy-N-[3-(2-piperidin-4-yl-ethylcarbamoyl)-benzyl]-benzamide | IC50 | 5000.0 [1] |
| 3,4-Dimethoxy-N-[3-(2-methyl-1,2,3,4-tetrahydro-isoquinolin-7-ylcarbamoyl)-benzyl]-benzamide | IC50 | 5000.0 [1] |
| 3-[[(4-Carbamoylphenyl)carbamoylamino]methyl]-N-(1,2,3,4-tetrahydroisoquinolin-7-yl)benzamide | IC50 | 770.0 [1] |
| 2-(Benzylamino)-N-(7-chloro-1-oxo-1,2-dihydroisoquinolin-6-yl)acetamide | IC50 | 3000.0 [1] |
| N-[5-[6-(Methylamino)pyrazin-2-yl]-2-oxo-1H-pyridin-3-yl]-4-[(2S)-2-(pyrrolidin-1-ylmethyl)pyrrolidin-1-yl]benzamide | Ki | 1000.0 [1] |
| (4S,6Z,10S)-10,18-Dihydroxy-16-methoxy-4-methyl-3-oxabicyclo[12.4.0]octadeca-1(14),6,15,17-tetraene-2,8-dione | IC50 | 10000.0 [1] |
| Infigratinib phosphate | IC50 | 10000.0 [1] |
| 2-[3-(3-Piperazin-1-ylpropoxy)phenyl]-N-(4-pyridin-4-yl-1,3-thiazol-2-yl)acetamide | IC50 | 10000.0 [1] |
| 7-[3-(Azetidin-1-ylmethyl)cyclobutyl]-5-[3-(7-oxabicyclo[2.2.1]heptan-1-ylmethoxy)phenyl]pyrrolo[2,3-d]pyrimidin-4-amine | IC50 | 10000.0 [1] |
| 1-[4-[3-[4-Amino-5-[2-fluoro-3-[[(2S)-oxolan-2-yl]methoxy]phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclobutyl]piperazin-1-yl]ethanone | IC50 | 10000.0 [1] |
| N~1~-[2-(1h-Indazol-5-Yl)pyrido[3,4-D]pyrimidin-4-Yl]-2-Methylpropane-1,2-Diamine | IC50 | 742.0 [1] |
| 9-[[8-Fluoro-6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]-4-methyl-[1,4]oxazino[3,2-c]quinolin-3-one | IC50 | 30000.0 [1] |
| 2-(1H-Indazol-5-yl)-4-piperazin-1-ylpyrido[3,4-d]pyrimidine | IC50 | 974.0 [1] |